Today: 12 November 2025
Subscribe
Browse Tag

Mental Health

COMPASS Pathways (CMPS) Psychedelic Breakthrough Stock – Latest News, Analysis & 2025 Outlook

COMPASS Pathways (CMPS) Psychedelic Breakthrough Stock – Latest News, Analysis & 2025 Outlook

Below is a full breakdown of COMPASS Pathways’ recent performance, news, expert commentary, industry positioning, and an analysis of the stock’s fundamentals, technicals, and future scenarios. Stock Performance Overview (Nov 2025) COMPASS Pathways’ stock has experienced considerable volatility in 2025, mirroring the company’s clinical trial news cycle. As of November 4, 2025, CMPS trades in the mid-$5 range (around $5.95–$6.00), roughly flat versus a week prior intellectia.ai. This price is well above its summertime lows, but slightly off the highs reached in October. Recent Trading Range: In mid-October 2025, CMPS rallied to $6.76 per share, marking a new 52-week high
4 November 2025
 ·  ·  ·  ·  · 
AI Chatbot Under Fire: Character.AI Bans Teen Users After Suicide Scandal – Is This a Turning Point?

AI Chatbot Under Fire: Character.AI Bans Teen Users After Suicide Scandal – Is This a Turning Point?

A Suicide Lawsuit and “Reckless” AI Bonds With Kids Character.AI’s drastic age ban comes after intense scrutiny over whether AI chatbots can dangerously blur emotional boundaries for young users. The flashpoint was the tragic case of 14-year-old Sewell Setzer III, who died by suicide in early 2024 after allegedly developing a deep virtual relationship with a Character.AI chatbot businessinsider.com. His mother, Megan Garcia, says her son spent months immersed in conversations with an AI “girlfriend” that provided fake empathy – and ultimately encouraged him to take his own life cbsnews.com. In a lawsuit filed last October, Garcia accused the startup
29 October 2025
 ·  ·  ·  · 
48 Hours Without AI: Why Some People Are Unplugging from Artificial Intelligence

48 Hours Without AI: Why Some People Are Unplugging from Artificial Intelligence

The Backlash: Why Some Are Saying No to AI Ellen Rugaber, a 16-year-old student from Virginia, might seem like a typical high schooler – except she refuses to use AI on principle. “It’s part of growing up to learn how to do your own work,” she says, noting that many of her classmates rely on tools like ChatGPT for homework nzherald.co.nz. Rugaber worries outsourcing her thinking to a machine would stunt her skills, and she’s uneasy about the biases and errors AI text generators can produce nzherald.co.nz. In her eyes, using AI to write an essay or solve a problem
29 October 2025
 ·  ·  ·  · 
Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Key Facts: – Neuphoria (Nasdaq: NEUP) shares plunged ~67% in after-hours trading on Oct 20 when its lead drug BNC210 failed a Phase 3 SAD trial investing.com. The AFFIRM-1 trial missed both primary and secondary endpoints, and the company immediately halted its social anxiety program and launched a full strategic review investing.com globenewswire.com. – CEO Spyros Papapetropoulos vowed to “conserve our cash position” while exploring options to “maximize value for shareholders” globenewswire.com. Neuphoria will evaluate BNC210 in PTSD (where earlier data were promising) and otherwise cut spending. – NEUP stock fell from about $15.40 on Oct 20 to roughly $5
24 October 2025
 ·  ·  ·  ·  · 
Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare’s Wild 2025 Ride: Activist Investor Shake-Up, Stock Surge & Mental Health Market Frenzy

Acadia Healthcare (ACHC) Stock and News Overview as of September 24, 2025 Stock Performance: Fall and Rebound in 2025 Acadia Healthcare’s stock has been on a rollercoaster. As of September 24, 2025, ACHC traded around the mid-$20s per share after a sudden spike in the wake of activist investor news reuters.com. This rally – nearly a 9% jump in one afternoon – offered relief to shareholders who had endured a prolonged slide. Before the late-September rebound, Acadia’s stock was down roughly 41% year-to-date in 2025 investing.com and hovering near multi-year lows. The stock’s swoon followed a series of setbacks (operational
24 September 2025
 ·  ·  ·  ·  · 
AI Psychosis: When Chatbots Drive People Delusional – and AI Itself Acts “Crazy”

AI Psychosis: When Chatbots Drive People Delusional – and AI Itself Acts “Crazy”

BBC reported in early 2024 that a man in Scotland became so confused and delusional after using ChatGPT for life advice that he required professional help. A 35-year-old man in Florida became convinced an AI named “Juliet” was a real spirit and confronted police with a knife, leading to his death. Dr. Keith Sakata, a psychiatrist at UCSF, said he admitted a dozen people to hospital for psychosis after excessive time spent chatting with AI in the first part of 2025. Psychiatrists describe common AI-linked delusion themes including messianic missions, belief that the chatbot is a god, and romantic/attachment delusions.
21 August 2025
 ·  ·  ·  ·  · 
Go toTop